(Date:12/15/2009)... the Lupus Foundation of America and the Saint Thomas, ... -- Julian Lennon, son of the legendary John Lennon, ... single, "LUCY," to raise funds for research on the ... percent of the proceeds from downloading "LUCY" at iTunes ... (LFA), and the Saint Thomas, Lupus Trust in Great ...
(Date:12/15/2009)... Incidence fell in area where all couples of reproductive ... 14 (HealthDay News) -- The number of children born ... who might be CF mutation carriers increases, a new ... in an area of northeast Italy for many years. ... progressive decline in the number of infants born with ...
(Date:12/15/2009)... have lower strength than needed for protection, CDC says, ... children,s doses of H1N1 swine flu vaccine have been ... lost some potency, federal health officials said Tuesday. , ... Prevention, the company,s routine testing of the vaccine for ... that four batches had lower than required potency levels. ...
(Date:12/15/2009)... Interactive education program will train advocates to be ... Project developed with support from experts in ... ,, WASHINGTON, Dec. 15 ... they are accepting applications for the first-ever "Malaria ... train and educate participants to become leaders in ...
(Date:12/15/2009)... PLAINS, N.Y., Dec. 15 Team In ... groundbreaking charity sports training program, has ... to support blood cancer research and patient services. ... been the pre-eminent charity endurance sports training program, ... marathon, half marathon, triathlon, 100-mile century cycle ride ...
Breaking Medicine News(10 mins):Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3... half of those in ICU had deficient levels, study shows ... are deficient in many critically ill patients, new research shows. ... half of people in an intensive care unit were deficient ... be common in seriously ill patients," said study author Dr. ...
... April 29 Varian Medical Systems (NYSE: ... of $0.64 per diluted share in the second quarter ... operations of $0.57 per diluted share in the year-ago ... net earnings per diluted share in the quarter were ...
... SGMO ) today reported first quarter 2009 financial ... 2009, Sangamo reported a consolidated net loss of $6.8 million, ... $8.0 million, or $0.20 per share, for the same period ... cash and cash equivalents, marketable securities and interest receivable of ...
... improves quality of sleep for patients, study finds, , , ... used to treat epilepsy, nerve pain, anxiety and fibromyalgia, ... syndrome, a Spanish researcher reports. , Some 5 percent ... have restless legs syndrome (RLS), a disorder that causes ...
... to the American Red Cross and receive a scratch ticket ... for a yearDEDHAM, Mass., April 29 During the month ... drives in Massachusetts, New Hampshire and Connecticut, along with select ... to "Scratch & Win with Uno Chicago Grill(R)." The Boston-based ...
... 29 Speaker Nancy Pelosi spoke ... final House-Senate budget resolution for fiscal year 2010. The resolution passed ... expected to be approved by the Senate later today. It does ... remarks: "Madam Speaker, it is indeed an honor ...
Other Medicine News:Health News:Critically Ill Patients Lack Vitamin D 2Health News:Critically Ill Patients Lack Vitamin D 3Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 2Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 3Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 4Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 5Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 6Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 7Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 8Health News:Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009 9Health News:Sangamo BioSciences Reports First Quarter 2009 Financial Results 2Health News:Sangamo BioSciences Reports First Quarter 2009 Financial Results 3Health News:Sangamo BioSciences Reports First Quarter 2009 Financial Results 4Health News:Sangamo BioSciences Reports First Quarter 2009 Financial Results 5Health News:Sangamo BioSciences Reports First Quarter 2009 Financial Results 6Health News:Sangamo BioSciences Reports First Quarter 2009 Financial Results 7Health News:Common Drug Eases Restless Legs Syndrome 2Health News:Try Your Luck with 'Scratch & Win with Uno Chicago Grill'! 2Health News:Try Your Luck with 'Scratch & Win with Uno Chicago Grill'! 3Health News:Pelosi: Budget is a Blueprint for the Future 2Health News:Pelosi: Budget is a Blueprint for the Future 3Health News:Pelosi: Budget is a Blueprint for the Future 4(Date:12/15/2009)... KV Pharmaceutical Company ( KVa/KVb) today announced that ... notice (the "Notice") executed by the Marc S. Hermelin ... requesting that the Board of Directors of the Company ... by written consent relating to the proposed appointment of ... from Ronald J. Kanterman,s departure (the "Director Appointment"). ,, ...
(Date:12/15/2009)... PITTSBURGH, Dec. 15 Ever wonder what something ... samples! ASPEX, makers of the Personal Scanning Electron Microscope ... encouraging people to send in samples to be scanned ... PSEM has a scan range of 100nm to 5mm ... the smallest samples into focus. In addition, ASPEX will ...
(Date:12/15/2009)... the best plan at the right price ... end of the year, thousands of Nebraska Medicare beneficiaries ... This is when the state,s 268,000 Medicare beneficiaries ... up and pay for in 2010. ,, Prescription ... says Independent Retail Pharmacist Steve Osenbaugh, of Lincoln. ...
Breaking Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign 2Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2GSK to Announce Q2 Results July 22 2009 51962 1Nile Therapeutics Inc Completes 243 4 Million Private Placement 13072 1Nile Therapeutics Inc Completes 243 4 Million Private Placement 13072 2Nile Therapeutics Inc Completes 243 4 Million Private Placement 13072 3Immucor Appoints Chief Operating Officer 51955 1Immucor Appoints Chief Operating Officer 51955 2... SUNNYVALE, Calif., June 27, 2007,/PRNewswire-FirstCall/ -- Pharmacyclics, ... multi-center Phase 2,clinical trials supporting the potential ... lead product,candidate, in combination with Alimta(R) (pemetrexed) ... second-line treatment,for patients with non-small cell lung ...
... OSS, the Netherlands, June 27, 2007-Organon, the human,healthcare ... two,out of three Phase III clinical trials with ... have reached,their randomization target. , ,Corifollitropin alfa ... first of a new class of gonadotropins (a ...
Other Medicine Technology:Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 2Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 3Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 4Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 5Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 2Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 3The cemented hip joint prosthesis system....
The Quatroloc primary hip system offers 35 primary stems to fit almost all femurs for primary hip arthroplasty....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
The standard of proximal press-fit design. The CLS hip is a straight stem design that is available in 13 sizes in two different neck angles, 135 and 145, to accommodate a wide variety of patient anat...
Medicine Products:Biology NavigationMedical Navigation